Safety, Tolerability and Effectiveness of Natalizumab in Adolescents With Active Crohn's Disease

Clinical trial NCT00055367 · COMPLETED

Trial details

NCT number: NCT00055367
Sponsor: Biogen
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Crohn's Disease

Start date: 2002-04-01
Primary completion: 2004-05-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.